Recherchiere Firmenbekanntmachungen und finanzielle Kennzahlen
EU-Förderung (6.293.855 €): Starke Bekämpfung von Kinderkrebs: eine Übungsintervention für Kinder und Jugendliche, die sich einer Krebsbehandlung unterziehen Hor11.02.2021 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Auf einen Blick
Text
Starke Bekämpfung von Kinderkrebs: eine Übungsintervention für Kinder und Jugendliche, die sich einer Krebsbehandlung unterziehen
Cancer is the first leading cause of death by non-communicable diseases in children in Europe. During cancer treatment, patients’ morbidity is increased due to physical inactivity, cancer-related fatigue (CRF) and reduced health-related quality of life (HRQoL). Adapted exercise training in cancer patients, called exercise oncology, is an increasingly recognised, promising health care intervention. In adults, exercise oncology revealed notable effects on tolerance and completion rate of cancer treatment. However, in childhood cancer patients, strong evidence for exercise efficiency is lacking. Thus, precision exercise training is not part of standard care in paediatric oncology and does not reach the majority of patients. By pooling the leading expertise on a European and cross-Atlantic level, the FORTEe project aims to evaluate a personalised and standardised exercise intervention for children and adolescents undergoing anti-cancer treatment. In the randomised, controlled FORTEe trial, high evidence for an innovative, patient-centred exercise treatment will be generated. FORTEe promotes exercise oncology that aims at making patients “stronger to fight childhood cancer”. Supervised exercise training intents to increase muscle strength and reduce muscular atrophy due to bedrest. CRF and HRQoL can be improved and in the future, these benefits may help to fight childhood cancer by increasing therapy efficiency and survival rate. Within the project, digital, innovative technologies such as augmented reality will be developed and applied to make the exercise training more effective, age-adapted and personalised. Moreover, FORTEe will stimulate translational research to provide access to paediatric exercise oncology as a new health care intervention. As a progress beyond the current state-of-the-art, FORTEe has the ambition to implement paediatric exercise oncology as an evidence-based standard in clinical care for all childhood cancer patients across the EU and beyond.
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| CONCENTRIS RESEARCH MANAGEMENT GmbH | 569.750 € |
| Centre de Lutte Contre le Cancer Leon Berard | 313.813 € |
| 73.500 € | |
| Fondazione Irccs Istituto Nazionale DEI Tumori | 278.513 € |
| 698.440 € | |
| 140.375 € | |
| 55.375 € | |
| NUROGAMES GmbH | 347.000 € |
| Oxford Brookes University | 672.991 € |
| PIXFORMANCE SPORTS GmbH | 76.250 € |
| Region Hovedstaden | 390.640 € |
| 92.671 € | |
| UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ | 1.704.398 € |
| UNIVERSITATSKLINIKUM HEIDELBERG | 484.869 € |
| Universidad Europea de Madrid SA | 296.764 € |
| 98.507 € |
Quelle: https://cordis.europa.eu/project/id/945153
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.
Die Visualisierungen zu "CONCENTRIS RESEARCH MANAGEMENT GmbH - EU-Förderung (6.293.855 €): Starke Bekämpfung von Kinderkrebs: eine Übungsintervention für Kinder und Jugendliche, die sich einer Krebsbehandlung unterziehen"
werden von
North Data
zur Weiterverwendung unter einer
Creative Commons Lizenz
zur Verfügung gestellt.
